STAT1d
Trump’s FDA navigates layoffs, exits, and a new hire
The Trump administration has started rehiring some of the FDA employees it fired last week, the latest chapter in a haphazard ...
BioSpace11h
How SpringWorks Took Pfizer’s Rare Disease Ghost Drug and Got It to Patients
SpringWorks Therapeutics sprung out of Pfizer’s storeroom, when a rare disease advocacy group pushed to keep a program for ...
Peninsula drugmaker nails heart failure drug launch in battle with Big Pharma
But the direct-to-consumer ad didn't come from Palo Alto-based Bridge Bio (Nasdaq: BBIO); instead it was produced by Pfizer ...
HealthTech4h
How AI Drug Manufacturing Is Changing the Game
Artificial intelligence improves process control and reduces the time required to produce key products such as the COVID-19 ...
BioPharma Dive2d
Summit partners with Pfizer to study bispecific, ADC combinations
The partners will test Summit’s ivonescimab alongside Pfizer’s antibody-drug conjugates in hopes of finding “potentially ...
STAT2d
Pfizer CEO Albert Bourla inflicts injury on his company — and all of pharma
The hiring of a former top FDA official amplifies "revolving door" criticism at the worst possible time, STAT's Adam ...